Apotex Pulls Antitrust Suit Vs. Allergan Over Acular Patent
The lawsuit had been pending in the U.S. District Court for the Northern District of California.
The lawsuit was based on allegations concerning a patent infringement action brought by Allergan and Syntex LLC against the Apotex defendants over their plans to launch a generic version of Allergan's non-steroidal anti-inflammatory drug Acular.
Last week, U.S. District Court Judge Martin Jenkins held that the patent...
To view the full article, register now.